ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,646Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 387

$1.01M Total Retail Price of All Prescriptions

Rank: 30 out of 387

561 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
4% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 561 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 561 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 13,033 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 501 491 1 2
OMEPRAZOLE 462 438 2 4
SIMVASTATIN 444 422 3 5
HYDROCODONE-ACETAMINOPHEN 421 409 S3 4 1
AMLODIPINE BESYLATE 353 349 5 6
LISINOPRIL 340 308 6 3
POTASSIUM CHLORIDE 282 279 7 9
METOPROLOL SUCCINATE 270 264 8 18
CARVEDILOL 251 230 9 21
ZOLPIDEM TARTRATE 230 218 10 16
FUROSEMIDE 221 218 11 7
DIOVAN 220 200 12 33
CRESTOR 218 207 13 34
WARFARIN SODIUM 211 194 14 17
LOSARTAN POTASSIUM 199 197 15 24
HYDROCHLOROTHIAZIDE 178 173 16 12
PRAVASTATIN SODIUM 178 167 16 15
TAMSULOSIN HCL 173 173 18 32
BYSTOLIC 164 124 19 112
ATORVASTATIN CALCIUM 143 143 20 13
ATENOLOL 139 127 21 20
LEVOFLOXACIN 139 133 21 84
AMLODIPINE BESYLATE-BENAZEPRIL 135 123 23 54
FENOFIBRATE 126 101 24 106
PANTOPRAZOLE SODIUM 122 122 25 48
METFORMIN HCL ER 118 115 26 81
FINASTERIDE 115 115 27 95
CLOPIDOGREL 114 112 28 25
CIPROFLOXACIN HCL 112 110 29 56
NEXIUM 109 99 30 26
TRAMADOL HCL 107 107 31 14
SERTRALINE HCL 106 97 32 23
AMITRIPTYLINE HCL 104 104 R 33 62
BENICAR 97 96 34 165
TRAZODONE HCL 95 83 35 37
ALLOPURINOL 93 80 36 28
VERAPAMIL ER 87 84 37 87
EXFORGE 87 87 37 157
PLAVIX 85 84 39 39
RAMIPRIL 85 85 39 119
ALENDRONATE SODIUM 84 84 41 31
MELOXICAM 83 83 42 22
PRISTIQ ER 83 71 42 319
GABAPENTIN 83 82 42 10
CITALOPRAM HBR 80 79 45 19
ACIPHEX 78 78 46 261
JANUVIA 76 72 47 60
DIGOXIN 74 74 48 40
LOSARTAN-HYDROCHLOROTHIAZIDE 74 74 48 65
CYCLOBENZAPRINE HCL 72 72 R 50 42
METFORMIN HCL 72 72 50 8
DIOVAN HCT 68 68 52 74
NIASPAN 67 67 53 164
ADVAIR DISKUS 67 59 53 41
SPIRONOLACTONE 65 65 55 67
METOPROLOL TARTRATE 64 64 56 11
SYNTHROID 63 63 57 68
TRAMADOL HCL-ACETAMINOPHEN 62 62 58 180
ESTRADIOL 62 60 R 58 105
KLOR-CON M20 62 61 58 76
ESCITALOPRAM OXALATE 61 59 61 73
NAPROXEN 59 56 62 89
FLUTICASONE PROPIONATE 59 59 62 29
GEMFIBROZIL 59 59 62 93
PREMARIN 58 46 R 65 77
BENAZEPRIL HCL 57 57 66 86
DICLOFENAC SODIUM 57 57 66 115
FLUOXETINE HCL 57 57 66 46
SINGULAIR 54 45 69 83
DOXYCYCLINE HYCLATE 54 54 69 114
FLUCONAZOLE 53 48 71 160
ACTOS 52 52 72 99
BISOPROLOL-HYDROCHLOROTHIAZIDE 52 52 72 144
RANITIDINE HCL 51 47 74 45
KLOR-CON 10 50 50 75 124
WELCHOL 50 49 75 296
MONTELUKAST SODIUM 50 42 75 152
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.